Palisade Bio Inc (PALI) support and resistance · P/E 15, rev $500.0K
Palisade Bio Inc (PALI) is a biotechnology company listed on NASDAQ.
This page maps Palisade Bio Inc (PALI) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PALI revenue for 2026-06-30 was $500.0K. Net income was -$20.2M. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
PALI currently screens at market cap $316.3M and trailing P/E 15.2. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PALI 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PALI quote page for the session range and the stock page for the full model.
Not investment advice.